Home > Financial Ratios > LYKA LABS

LYKA LABS
Core EBITDA Growth

    Back to All Ratios
LYKA LABS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LYKA LABS
Please provide your vote to see the results

LYKA LABS Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) -15.17-80.40385.973,765.48-402.66

What is the latest Core EBITDA Growth ratio of LYKA LABS ?

The latest Core EBITDA Growth ratio of LYKA LABS is -15.17 based on Mar2024 Consolidated results.
Year Core EBITDA Growth
Mar2024-15.17
Mar2023-80.40
Mar2022385.97
Mar20213,765.48
Mar2020-402.66

How is Core EBITDA Growth of LYKA LABS Trending?

Years Core EBITDA Growth % Change
Mar2024 -15.17
Negative
Mar2023 -80.4
Negative
Mar2022 385.97
-89.75
Mar2021 3765.48
Positive
Mar2020 -402.66 -

Other Financial Ratios of LYKA LABS


Compare Core EBITDA Growth ratio of peers of LYKA LABS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LYKA LABS ₹556.0 Cr -1.3% -3.7% 22.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹424,382.0 Cr -3.7% -2.5% 31.9% Stock Analytics
DIVIS LABORATORIES ₹159,224.0 Cr 2.3% 2.1% 46.9% Stock Analytics
CIPLA ₹116,943.0 Cr -3.2% 0% 8.2% Stock Analytics
DR REDDYS LABORATORIES ₹111,588.0 Cr -2.4% 7.3% 15.3% Stock Analytics
ZYDUS LIFESCIENCES ₹100,704.0 Cr 2% 2.3% 37.9% Stock Analytics


LYKA LABS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
LYKA LABS

-1.3%

-3.7%

22.8%

SENSEX

-2.2%

-5.9%

7.2%


You may also like the below Video Courses